Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma.
Matoba Y, Zarrella DT, Pooladanda V, Azimi Mohammadabadi M, Kim E, Kumar S, Xu M, Qin X, Ray LJ, Devins KM, Kumar R, Kononenko A, Eisenhauer E, Veillard IE, Yamagami W, Hill SJ, Sarosiek KA, Yeku OO, Spriggs DR, Rueda BR.
Matoba Y, et al. Among authors: hill sj.
Br J Cancer. 2024 Mar 4. doi: 10.1038/s41416-024-02621-x. Online ahead of print.
Br J Cancer. 2024.
PMID: 38438589